Corrigendum: A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics.

[This corrects the article on p. 357 in vol. 6, PMID: 26858745.].

With regards to Figure 3: Significant relationships and non-significant relationships for CDx price, the graph (A) of CDx Price vs. CDx Sensitivity as well as the corresponding legend, is in error. Graph A wrongly depicts a trendline unadjusted for outlier effect, and the correct graph, as described in the text, is shown below. The corresponding legend has been likewise corrected to reflect the correct graph title and statistical values described in the text. This correction does not affect the scientific validity of the results, as the discrepancy was with the presentation of results.

Figure 3

Significant relationships and non-significant relationships for CDx price. (A) There is a significant relationship between CDx price and CDx sensitivity (R2 = −0.10, p = 0.04). (B) There are non-significant relationships between CDx price and drug price (R2 = 0.043, p = 0.70) and (C) the total patient population (R2 = 0.105 p = 0.59).

Author contributions

All authors listed, have made substantial, direct and intellectual contribution to the work, and approved it for publication.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.